Case report describes treatment outcome for a toddler with persistent fever, highlighting clinical challenges.
Multisystem Inflammatory Syndrome in Children is a serious complication associated with coronavirus disease 2019 that commonly affects individuals under 19 years of age. This condition can present with a wide spectrum of clinical manifestations, some of which may be severe or life-threatening. Management can be challenging due to the variability in clinical presentation and response to therapy. This report describes the case of a toddler with no previously documented severe acute respiratory syndrome coronavirus 2 infection who presented with a 30-day relapsing fever that demonstrated partial response to antipyretics and was associated with gastrointestinal symptoms and a skin rash. Following extensive clinical and laboratory investigations, the patient was diagnosed with multisystem inflammatory syndrome in children and was successfully treated with intravenous immunoglobulin and corticosteroids.
No takes yet. Share an insight, caveat, or question.
Katranjy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: